Acumapimod Significantly Reduces Key Inflammatory Biomarkers in Severe COPD Exacerbations and Reduces the Rate of Re-Hospitalization - KIVIRID

Acumapimod Significantly Reduces Key Inflammatory Biomarkers in Severe COPD Exacerbations and Reduces the Rate of Re-Hospitalization

Authors: J. Fettiplace, J. Parkin, J.A. Wedzicha

Published: 2025-05-11

DOI: 10.1164/ajrccm.2025.211.abstracts.a5237

Source: Full article

Abstract

No abstract found.